Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants | Nature
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
SARS-CoV-2 variants, spike mutations and immune escape | Nature Reviews Microbiology
Hepatitis E virus infection | Nature Reviews Disease Primers
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum | Nature Immunology
Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon | PLOS ONE
Microorganisms | Free Full-Text | Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins | HTML
Hepatitis E virus infection | Nature Reviews Disease Primers
Declining prevalence of hepatitis A and silent circulation of hepatitis E virus infection in southeastern Brazil - International Journal of Infectious Diseases
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery | Nature Communications
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
Structural biology of SARS-CoV-2: open the door for novel therapies | Signal Transduction and Targeted Therapy
A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization - ScienceDirect
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet
Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19 - ScienceDirect
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study - The Lancet Infectious Diseases
The Global Prevalence of Hepatitis A Virus Infection and Susceptibility: A Systematic Review
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
A systematic review of SARS-CoV-2 vaccine candidates | Signal Transduction and Targeted Therapy
Microorganisms | Free Full-Text | Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins | HTML
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
Viruses | Free Full-Text | Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection | HTML
